Application Nr Approved Date Route Status External Links
NDA208254 None Topical None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Rhopressa (Netarsudil Ophthalmic Solution) 0.02% Is Indicated For The Reduction Of Elevated Intraocular Pressure (Iop) In Patients With Open-Angle Glaucoma Or Ocular Hypertension. Rhopressa ® (Netarsudil Ophthalmic Solution) 0.02% Is A Rho Kinase Inhibitor Indicated For The Reduction Of Elevated Intraocular Pressure In Patients With Open-Angle Glaucoma Or Ocular Hypertension. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Netarsudil Mesylate

Comments